BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.78
0.80%
After-hours: Aug 15, 2025, 06:01 PM EDT

BioLineRx Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-74.15 -66.54 -48.8 -133.3
PEG Ratio
0.84 -0.7 2.32 2.02
PS Ratio
23.63 840.27 n/a n/a
PB Ratio
50.79 305.02 23.95 52.97
P/FCF Ratio
-15.56 -176.09 -45.85 -152.36
P/OCF Ratio
-15.58 -178.4 -46.41 -152.99
OCF/S Ratio
-1.52 -4.71 n/a n/a
Debt / Equity Ratio
1.12 0.88 0.24 0.07
Quick Ratio
1.56 1.06 4.85 5.89
Current Ratio
1.76 1.10 4.87 5.91
Asset Turnover
0.74 0.08 n/a n/a
Interest Coverage
-2.25 -22.91 -13.51 -25.18
Return on Equity
-0.69 -4.58 -0.49 -0.4
Return on Assets
-0.24 -0.95 -0.33 -0.33
Return on Invested Capital
-0.72 -2 -0.43 -0.33
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.68 0.23 n/a n/a
Net Profit Margin
-0.32 -12.63 n/a n/a
Pretax Profit Margin
-0.32 -12.63 n/a n/a
Operating Profit Margin
-0.71 -10.35 n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.14 -11.89 n/a n/a